Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: Tolerance and activity in ovarian cancer

Tamar Safra, Susan Jeffers, Joan Sorich, Franco M. Muggia*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: Tolerance and activity in ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences